|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
2007-7-19
|
|
pubmed:abstractText |
Using data from men in the finasteride group of the Prostate Cancer Prevention Trial (PCPT), we evaluated the impact of prostate-specific antigen (PSA) and other risk factors on the risk of prostate cancer.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3076-81
|
|
pubmed:dateRevised |
2007-12-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17634486-Administration, Oral,
pubmed-meshheading:17634486-Aged,
pubmed-meshheading:17634486-Biopsy, Needle,
pubmed-meshheading:17634486-Confidence Intervals,
pubmed-meshheading:17634486-Digital Rectal Examination,
pubmed-meshheading:17634486-Disease-Free Survival,
pubmed-meshheading:17634486-Dose-Response Relationship, Drug,
pubmed-meshheading:17634486-Drug Administration Schedule,
pubmed-meshheading:17634486-Finasteride,
pubmed-meshheading:17634486-Follow-Up Studies,
pubmed-meshheading:17634486-Humans,
pubmed-meshheading:17634486-Immunohistochemistry,
pubmed-meshheading:17634486-Male,
pubmed-meshheading:17634486-Middle Aged,
pubmed-meshheading:17634486-Multivariate Analysis,
pubmed-meshheading:17634486-Neoplasm Staging,
pubmed-meshheading:17634486-Odds Ratio,
pubmed-meshheading:17634486-Predictive Value of Tests,
pubmed-meshheading:17634486-Preventive Medicine,
pubmed-meshheading:17634486-Probability,
pubmed-meshheading:17634486-Prostate-Specific Antigen,
pubmed-meshheading:17634486-Prostatic Neoplasms,
pubmed-meshheading:17634486-Risk Assessment,
pubmed-meshheading:17634486-Survival Analysis,
pubmed-meshheading:17634486-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
|
|
pubmed:affiliation |
Department of Urology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA. thompsoni@uthscsa.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
